Obesity and the gut microbiome: Pathophysiological aspects

Hormone Molecular Biology and Clinical Investigation

Volumn 17, Issue 1, 2014, Pages 53-61

  Bradlow, H Leon ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetes; Firmicutes; Gut microbiome; Inflammation; Obesity

Indexed keywords

DEOXYCHOLIC ACID; ENDOTOXIN; LIPOPOLYSACCHARIDE; ANTIBIOTIC AGENT; DIGOXIN; MILK FAT; PREBIOTIC AGENT; PROBIOTIC AGENT; SAFFLOWER OIL; SEX HORMONE;

AKKERMANSIA; AKKERMANSIA MUCINIPHILA; BACTERIAL FLORA; BACTERIAL STRAIN; BACTEROIDES; CECUM; CHRONIC INFLAMMATION; FIRMICUTES; FOOD INTAKE; HUMAN; INTESTINE FLORA; INTESTINE WALL; MICROBIOME; MUCUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION; ANTIBIOTIC THERAPY; BACTERIAL METABOLISM; BODY COMPOSITION; BODY MASS; BREAST CANCER; CANCER RISK; COLITIS; HELICOBACTER HEPATICUS; LEAN BODY WEIGHT; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POSTMENOPAUSE; STOMACH BYPASS; ANIMAL; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; NEOPLASM; RISK FACTOR;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; NEOPLASMS; OBESITY; RISK FACTORS;

EID: 84928650225     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2013-0063     Document Type: Review

References (59)

1. Barreira TV, Staiano AE, Harrington DM, Heymsfield SB, Smith SR, Bouchard C, Katzmarzyk PT. Anthropometric correlates of total body fat, abdominal adiposity, cardiovascular disease risk factors in a biracial sample of men and women. Proc Mayo Clin 2012;87:452-60.
2. KathBritton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body Fa2 distribution, incident cardiovascular disease, cancer, all-cause mortality. J Am Coll Cardiol 2013;62:921-5.
3. Lean MJ. Prognosis in obesity. BMJ 2005;330:1339-40.
4. Sinicrope FA, Dannenber AJ. Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol 2;29:4-7.
5. Foxhall LE. The obesity-cancer connection, what we can do about it. American Cancer Society 2013. Available from: http:// www.cancer.org/cancer/ news/expertvoices/post/2013/02/28/ the-obesity-cancer-connection-and-what-we- can-do-about-it. aspx.
6. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007;449:804-10.
7. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL, Rosenbaum M, Gordon JL. The long-term stability of the human gut microbiota. Science 2013;341:DOI:10.1126/ science.1237439.
8. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, Affourtit J, Egholm M, Henrissat B, Knight R, Gordon JI. Organismal, genetic, transcriptional variation in the deeply sequenced gut microbiomes of identical twins PNAS 2010;107:7503-8.
9. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-4.
10. Cani PD, Bibilont R, Knauf C, Waget A, Neyrinck AM. Changes in gut microbiota controls metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81.
11. Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013;498:99-103.
12. Musso G, Gambino R, Cassader M. Obesity, diabetes, gut microbiota. The hygiene hypothesis expanded? Diabetes Care 2010;33:2277-84.
13. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013;110:9066-71.
14. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, François P, de Vos WM, Delzenne NM, Schrenzel J, Cani PD. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obemse and diet-induced leptin-resistant mice. Diabetes 2011;60:2775-86.
15. Cani PD, Possemiers S, Van d Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinsk A, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability Gut 2009;58:1091-103.
16. Million M, Lagier J-C, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect 2013;19:305-13.
17. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci 2004;101:15718-23.
18. Looft T, Allen HK. Gut microbes. Collateral effects of antibiotics on mammalian gut microbiomes Gut Microbes 2012;3:463-7.
19. Turnbaugh PJ, Ridura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic assay in humanized gnotobiotic mice. Sci Transl Med 2009;1:6ra14.
20. Bäckhed F, Manchester JK, Semenkovich CF, Gordon J. Jeffrey Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007;104:979-84.
21. Huang EY, Leone VA, Devkota S, Wang Y, Brady MJ, Chang EB. Composition of dietary fat source, shapes gut microbiota architecture and alters host inflammatory mediators in mouse adipose tissue. J Parenter Enteral Nutr 2013;37:746-54.
22. Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell. 2013;152:39-50.
23. Freter R, Abrams GD. Function of various intestinal bacteria in converting germfree mice to the normal state. Infect Immun 1972;6:119-26.
24. Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, Shah N, Wang C, Magrini V, Wilson RK, Cantarel BL, Coutinho PM, Henrissat B, Crock LW, Russell A, Verberkmoes NC, Hettich RL, Gordon JI. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009;106:5859-64.
25. Turnbaugh PJ, Ruth E, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-103.
26. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Nature 2005;102:11070-5.
27. Devkota S, Turnbaugh PJ. Cancer: an acidic link. Nature 2013;499:37-8.
28. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97-101.
29. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bil acids as carcinogens in human gastrointestinal cancer. Mutat Res 2005;589:47-65.
30. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fatinduced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012;87:104-8.
31. Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JLA, Doernte AL, Williams M, McFaline JL, Essigmanm JM, Schauer DB, Tannenbaum SR, Dedone PC, Weinman SA, Lemon SM, Fry RC, Rogers AB. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 2010;59:88-97.
32. Modi SR, Lee HH, Spina CS, Colllins JJ. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 2013;499:219-22.
33. Million M, Lagier JC, Yahav D, Paul M. Gut bacterial microbiota and obesity. Clin Microbiol Infect 2013;19:305-13.
34. Ng KM, Ferreyra JA, Higgenbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, Sonnenburg JL. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013;502:96-9.
35. Micioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010;6:392-8.
36. Chen G, Pang Z. Endocanabinoids and Obesity. Vitm Horm 2013;91:325-68.
37. Liou AP, Paziuk M, Luevano JM, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013;5:178ra41.
38. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW, Bloom SR, Darzi A, Athanasiou T, Marchesi JR, Nicholson JK, Holmes E. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 2011;60:1214-23.
39. Wesemann DR, Portuguese AJ, Meyers RM, Gallagher MP, Cluff-Jones K, Magee J, Panchakshari RA, Rodig SJ, Kepler TB, Alt FW. Microbial colonization influences early B-lineage development in the gut lamina propria. Nature 2013;501:112-5.
40. Haiser HJ, Gootenberg DB, Chatman K, Sirasani G, Balskus EP, Turnbaugh PJ. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 2013;341:295-8.
41. Heijtz RD, Wang S, Oian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Fosberg H, Pettersson S. Normal gut microbiota modulates brain development and behavior. PNAS 2011;108:3047-52.
42. Elahi S, Ertelt JM, Kinder JM, Jiang TT, Zhang X, Xin L, Charturvedi V, Strong BS, Qualls JE, Steinbrecher KA, Kalfa TA, Shaaban AF. Immunosuppressive CD71 erythroid cells compromise neonatal host defense against infection. Nature (2013) DOI:10.1038/nature12675.
43. Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci USA 2012;109:594-9.
44. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Urself LK, Clement JC, Vantreuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI. Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice. Science 2013;341:1241214.
45. Le Chatelier E, Nielson T, Priti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M, Kenedy S, Leonard S, Li J, Burgdorf K, Grarup N, Jorgensen T, Branslund I, Nielsen HB, Sunagawa S, Tap J, Tims S. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-6.
46. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida, Quinquis aB, Levenz L, Galleron N, Gougis S, Rizkalla S, Batto J-M, Renault P, ANR MicroObes consortium, Dore J, Zucker J-D, Clement K, Ehrlich SD, Blottiere H, Leclerc M, Juste C, Wouters T, Lepage P, Fouqueray C. Dietary intervention impact on gut microbial gene richness. Nature 2013;500;585-8.
47. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE. Diet rapidly and reproducibly alters the human gut microbiome Nature doi:10.1038/nature12820.
48. Lee SM, Donaldson GP, Mikulski Z, Bovaiian S, Leym K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013;501;426-9.
49. Naukkarinen J, Heinonen S, Hakkarainen A, Lundbom J, Vuolteenaho K, Saarinen L, Hautaniemi S, Rodriguez A, Frühbeck G, Pajunen P, Hyötyläinen T, Orešic M, Moilanen E, Suomalainen A, Lundbom N, Kaprio J, Rissanen A, Pietiläinen KH. Characterising metabolically healthy obesity in weightdiscordant monozygotic twins. Diabetologia 2014;57:167-76.
50. Moore T, Rodriguez A, Bakken JS. Fecal Microbiota Transplantation: A Practical Update for the Infectious Disease Specialist. Clin Infect Dis 2014;58:541-5.
51. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003;37:42-7.
52. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012;36:503-16.
53. Louie T. Fecal Transplant Pills Effective for C difficile ID Week 2013. Abstract 89. Presented October 3, 2013.
54. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013;342:967-70.
55. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Bérard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Doré J, Kroemer G, Lepage P, Boneca IG, Ghiringhelli F, Zitvogel L. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013;342: 971-6.
56. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013;155:1451-63.
57. Faith JJ, Ahern PP, Ridura VK, Cheng J, Gordon JI. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med 2014:6:p. 220ra11.
58. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. A pathological and clinical entity. J Am Med Assoc 1932;9:1323-9.
59. Erickson AR, Cantarel BL, Lamendella R, Darzi Y, Mongodin EF, Pan C, Shah M, Halfvarson J, Tysk C, Henrissat B, Raes J, Verberkmoes NC, Fraser CM, Hettich RL, Jansson JK. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One 2012;7:e49138.